KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aquestive Therapeutics (AQST) Current Taxes (2017 - 2020)

Aquestive Therapeutics (AQST) has 3 years of Current Taxes data on record, last reported at $316000.0 in Q4 2020.

  • For Q4 2020, Current Taxes rose 5.33% year-over-year to $316000.0; the TTM value through Dec 2020 reached $316000.0, up 5.33%, while the annual FY2020 figure was $316000.0, 5.33% up from the prior year.
  • Current Taxes reached $316000.0 in Q4 2020 per AQST's latest filing, down from $370000.0 in the prior quarter.
  • Across five years, Current Taxes topped out at $388000.0 in Q4 2018 and bottomed at $176000.0 in Q2 2019.
  • Average Current Taxes over 3 years is $305888.9, with a median of $316000.0 recorded in 2020.
  • Peak YoY movement for Current Taxes: tumbled 33.08% in 2019, then rose 5.33% in 2020.
  • A 3-year view of Current Taxes shows it stood at $388000.0 in 2018, then decreased by 22.68% to $300000.0 in 2019, then rose by 5.33% to $316000.0 in 2020.
  • Per Business Quant database, its latest 3 readings for Current Taxes were $316000.0 in Q4 2020, $370000.0 in Q1 2020, and $300000.0 in Q4 2019.